Myomo (MYO) Depreciation & Amortization (CF) (2016 - 2025)
Myomo (MYO) posted Depreciation & Amortization (CF) of $246851.0 for Q3 2025, up 29.38% on a QoQ basis from $190798.0 in Q2 2025, and up 407.06% year-over-year from $48683.0 in Q3 2024.
Myomo (MYO) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends
Myomo's Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $246851.0 for Q3 2025.
- Quarterly Depreciation & Amortization (CF) rose 407.06% year-over-year to $246851.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $596091.0 (up 189.49% YoY) and the FY2024 annual result came in at $205910.0, up 25.32% from the prior year.
- Depreciation & Amortization (CF) was $246851.0 for Q3 2025 at Myomo, up from $190798.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $246851.0 in Q3 2025 and bottomed at $23313.0 in Q1 2021.
- A 5-year average of $68689.5 and a median of $48683.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 43.15% — and 2025, when it jumped 433.74%.
- Myomo's Depreciation & Amortization (CF) stood at $50757.0 in 2021, then fell by 3.35% to $49057.0 in 2022, then slumped by 43.15% to $27890.0 in 2023, then soared by 228.3% to $91564.0 in 2024, then soared by 169.59% to $246851.0 in 2025.
- Business Quant data shows MYO's Depreciation & Amortization (CF) at $246851.0 in Q3 2025, $190798.0 in Q2 2025, and $158442.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 246,851.00 |
| Sep 30, 2025 | 246,851.00 |
| Jun 30, 2025 | 190,798.00 |
| Jun 30, 2025 | 190,798.00 |
| Mar 31, 2025 | 158,442.00 |
| Mar 31, 2025 | 158,442.00 |
| Dec 31, 2024 | 91,564.00 |
| Dec 31, 2024 | 91,564.00 |
| Sep 30, 2024 | 48,683.00 |
| Sep 30, 2024 | 48,683.00 |
| Jun 30, 2024 | 35,978.00 |
| Jun 30, 2024 | 35,978.00 |
| Mar 31, 2024 | 29,685.00 |
| Mar 31, 2024 | 29,685.00 |
| Dec 31, 2023 | 27,890.00 |
| Dec 31, 2023 | 27,890.00 |
| Sep 30, 2023 | 35,794.00 |
| Sep 30, 2023 | 35,794.00 |
| Jun 30, 2023 | 51,990.00 |
| Jun 30, 2023 | 51,990.00 |